EJMK Ventures’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-561
Closed -$209K – 179
2026
Q2
$209K Buy
+561
New +$168K 0.09% 155

Other funds holding KRYS

EJMK Ventures's KRYS Position: Q3 2026 in Review

EJMK Ventures sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 561 shares — an estimated $209K sold.

EJMK Ventures first reported a position in KRYS in Q2 2026 and held it in 1 quarter. The position peaked at $209K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • EJMK Ventures reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
  • EJMK Ventures sold 561 Krystal Biotech shares in Q3 2026, an estimated $209K.
  • EJMK Ventures first reported a position in Krystal Biotech in Q2 2026 and held it in 1 quarter.
  • EJMK Ventures's Krystal Biotech position peaked at $209K in Q2 2026.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.